Effects of Aldosterone and Mineralocorticoid Receptor Blockade on Intracellular Electrolytes

被引:0
|
作者
Martin Wehling
机构
[1] University of Heidelberg,Institute of Clinical Pharmacology, Faculty for Clinical Medicine at Mannheim
[2] University of Heidelberg,Institute of Clinical Pharmacology, Faculty of Clinical Medicine Mannheim
来源
Heart Failure Reviews | 2005年 / 10卷
关键词
mineralocorticoids; intracellular electrolytes; rapid effects; second messengers;
D O I
暂无
中图分类号
学科分类号
摘要
Genomic mechanisms of mineralocorticoid action have been increasingly elucidated over the past four decades. In renal epithelia, the main effect is an increase in sodium transport through activation and de novo synthesis of epithelial sodium channels. This leads to increased concentrations of intracellular sodium activating sodium-potassium-ATPase molecules mainly at the basolateral membrane which extrude sodium back into the blood stream. In contrast, rapid steroid actions have been widely recognized only recently. The present article summarizes both traditional and rapid effects of mineralocorticoid hormones on intracellular electrolytes, e.g. free intracellular calcium in vascular smooth muscle cells as determined by fura 2 spectrofluorometry in single cultured cells from rat aorta. Latter effects are almost immediate, reach a plateau after only 3 to 5 minutes and are characterized by high specificity for mineralocorticoids versus glucocorticoids. The effect of aldosterone is blocked by neomycin and short-term treatment with phorbol esters but augmented by staurosporine, indicating an involvement of phospholipase C and protein kinase C. The Ca2+ effect appears to involve the release of intracellular Ca2+, as shown by the inhibitory effect of thapsigargin. This mechanism operates at physiological subnanomolar aldosterone concentrations and appears to result in rapid fine tuning of cardiovascular responsivity.
引用
收藏
页码:39 / 46
页数:7
相关论文
共 50 条
  • [1] Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes
    Wehling, M
    HEART FAILURE REVIEWS, 2005, 10 (01) : 39 - 46
  • [2] Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular Systems
    Yagi, Shusuke
    Akaike, Masashi
    Aihara, Ken-ichi
    Fukuda, Daiju
    Ishida, Masayoshi
    Ise, Takayuki
    Niki, Toshiyuki
    Sumitomo-Ueda, Yuka
    Yamaguchi, Koji
    Iwase, Takashi
    Taketani, Yoshio
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Shimabukuro, Michio
    Sata, Masataka
    ACTA CARDIOLOGICA SINICA, 2013, 29 (03) : 201 - 207
  • [3] Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation
    Joffe, HV
    Adler, GK
    HEART FAILURE REVIEWS, 2005, 10 (01) : 31 - 37
  • [4] Effect of Aldosterone and Mineralocorticoid Receptor Blockade on Vascular Inflammation
    Hylton V. Joffe
    Gail K. Adler
    Heart Failure Reviews, 2005, 10 : 31 - 37
  • [5] Aldosterone and the mineralocorticoid receptor
    Messaoudi, Smail
    Jaisser, Frederic
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0B) : B4 - B9
  • [6] Beneficial Effects of Proanthocyanidins in the Cardiac Alterations Induced by Aldosterone in Rat Heart through Mineralocorticoid Receptor Blockade
    Martin-Fernandez, Beatriz
    de las Heras, Natalia
    Valero-Munoz, Maria
    Ballesteros, Sandra
    Yao, Yi-Zhou
    Stanton, Peter G.
    Fuller, Peter J.
    Lahera, Vicente
    PLOS ONE, 2014, 9 (10):
  • [7] The tubulogenic effect of aldosterone is attributed to intact binding and intracellular response of the mineralocorticoid receptor
    Minuth, Will W.
    Denk, Lucia
    Hui, Kanghong
    Castrop, Hayo
    Gomez-Sanchez, Celso
    CENTRAL EUROPEAN JOURNAL OF BIOLOGY, 2007, 2 (03): : 307 - 325
  • [8] Effects of mineralocorticoid receptor blockade by spironolactone on vascular calcification
    Buehling, S. S.
    Alesutan, I.
    Feger, M.
    Voelkl, J.
    Lang, F.
    ACTA PHYSIOLOGICA, 2016, 216
  • [9] Selective mineralocorticoid receptor blockade attenuates aldosterone mediated dysfunction of endothelial progenitor cells
    Thum, T.
    Schmitter, K.
    Fraccarollo, D.
    Hahner, S.
    Allolio, B.
    Ertl, G.
    Bauersachs, J.
    JOURNAL OF HYPERTENSION, 2008, 26 : S76 - S76
  • [10] Aldosterone, Mineralocorticoid Receptor and the Metabolic Syndrome: Role of the Mineralocorticoid Receptor Antagonists
    Ronconi, Vanessa
    Turchi, Federica
    Appolloni, Gloria
    di Tizio, Valentina
    Boscaro, Marco
    Giacchetti, Gilberta
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (02) : 238 - 246